D4-PHARMA
ActiveSummary
The computed 12-month bankruptcy probability of D4-PHARMA is 1.9% (moderate). The 2025 annual accounts show equity of €167,820 and a net result of €15,203. Equity is shrinking by about 3% per year across the filed financial years. Its solvency ranks better than 20% of 12,578 sector peers (NACE 47, financial year 2025). The company has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals.
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 21 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
2 establishment units
2 parcels
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 21362B0273/00H008 | Brussels | 339 m² | 1 · 325 m² | 19.9 m · 6 |
| 21443A0147/00R005 | Brussels | 290 m² | 1 · 150 m² | 22.9 m · 6 |